Mohamad Moustafa Ali

Dr. Mohamad Moustafa Ali

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 February 2018 in Nature Communications
Verified
Journal Article
Open access
PDF file
MAMohamad Moustafa Ali
Mohamad Moustafa Ali
VAVijay Suresh Akhade
Vijay Suresh Akhade
SKSubazini Thankaswamy Kosalai
Subazini Thankaswamy Kosalai
SSSanthilal Subhash
Santhilal Subhash
LSLuisa Statello
Luisa Statello
CKChandrasekhar Kanduri
Chandrasekhar Kanduri
Despite improvement in our understanding of long noncoding RNAs (lncRNAs) role in cancer, efforts to find clinically relevant cancer-associated lncRNAs are still lacking. Here, using nascent RNA capture sequencing, we identify 1145 temporally expressed S-phase-enriched lncRNAs. Among these, 570 lncRNAs show significant differential expression in at least one tumor type across TCGA data sets. Systematic clinical investigation of 14 Pan-Cancer data sets identified 633 independent prognostic markers. Silencing of the top differentially expressed and clinically relevant S-phase-enriched lncRNAs in several cancer models affects crucial cancer cell hallmarks. Mechanistic investigations on SCAT7 in multiple cancer types reveal that it interacts with hnRNPK/YBX1 complex and affects cancer cell hallmarks through the regulation of FGF/FGFR and its downstream PI3K/AKT and MAPK pathways. We also implement a LNA-antisense oligo-based strategy to treat cancer cell line and patient-derived tumor (PDX) xenografts. Thus, this study provides a comprehensive list of lncRNA-based oncogenic drivers with potential prognostic value.

15 October 2014 in Cell Cycle
Verified
Journal Article
Closed access
MMMatthieu Meryet-Figuiere
Matthieu Meryet-Figuiere
BABabak Alaei-Mahabadi
Babak Alaei-Mahabadi
MAMohamad Moustafa Ali
Mohamad Moustafa Ali
SMSanhita Mitra
Sanhita Mitra
SSSanthilal Subhash
Santhilal Subhash
CKChandrasekhar Kanduri
Chandrasekhar Kanduri
Transcriptional events during S-phase are critical for cell cycle progression. Here, by using a nascent RNA capture assay coupled with high-throughput sequencing, we determined the temporal patterns of transcriptional events that occur during S-phase. We show that genes involved in critical S-phase-specific biological processes such as nucleosome assembly and DNA repair have temporal transcription patterns across S-phase that are not evident from total RNA levels. By comparing transcription timing with replication timing in S-phase, we show that early replicating genes show increased transcription late in S-phase whereas late replicating genes are predominantly transcribed early in S-phase. Global anti-correlation between replication and transcription timing was observed only based on nascent RNA but not total RNA. Our data provides a detailed view of ongoing transcriptional events during the S-phase of cell cycle, and supports that transcription and replication are temporally separated.

31 July 2022 in Cancers
Verified
Journal Article
Open access
PDF file
KKKonstantinos Kolliopoulos
Konstantinos Kolliopoulos
MAMohamad Moustafa Ali
Mohamad Moustafa Ali
CCCasimiro Castillejo-Lopez
Casimiro Castillejo-Lopez
CHCarl-Henrik Heldin
Carl-Henrik Heldin
Paraskevi HeldinParaskevi Heldin
Paraskevi Heldin
Glioblastoma multiforme (GBM) is a lethal brain tumor, characterized by enhanced proliferation and invasion, as well as increased vascularization and chemoresistance. The expression of the hyaluronan receptor CD44 has been shown to correlate with GBM progression and poor prognosis. Here, we sought to elucidate the molecular mechanisms by which CD44 promotes GBM progression by knocking out (KO) CD44, employing CRISPR/Cas9 gene editing in U251MG cells. CD44-depleted cells exhibited an impaired proliferation rate, as shown by the decreased cell numbers, decreased Ki67-positive cell nuclei, diminished phosphorylation of CREB, and increased levels of the cell cycle inhibitor p16 compared to control cells. Furthermore, the CD44 KO cells showed decreased stemness and increased senescence, which was manifested upon serum deprivation. In stem cell-like enriched spheres, RNA-sequencing analysis of U251MG cells revealed a CD44 dependence for gene signatures related to hypoxia, the glycolytic pathway, and G2 to M phase transition. Partially similar results were obtained when cells were treated with the γ-secretase inhibitor DAPT, which inhibits CD44 cleavage and therefore inhibits the release of the intracellular domain (ICD) of CD44, suggesting that certain transcriptional responses are dependent on CD44-ICD. Interestingly, the expression of molecules involved in hyaluronan synthesis, degradation, and interacting matrix proteins, as well as of platelet-derived growth factor (PDGF) isoforms and PDGF receptors, were also deregulated in CD44 KO cells. These results were confirmed by the knockdown of CD44 in another GBM cell line, U2990. Notably, downregulation of hyaluronan synthase 2 (HAS2) impaired the hypoxia-related genes and decreased the CD44 protein levels, suggesting a CD44/hyaluronan feedback circuit contributing to GBM progression.

8 November 2023 in Progress in Biophysics and Molecular Biology
Verified
Journal Article
Closed access
Mahmoud Ibrahim KahlilMahmoud Ibrahim Kahlil
Mahmoud Ibrahim Kahlil
MAMohamad Moustafa Ali
Mohamad Moustafa Ali
JHJasmine Holail
Jasmine Holail
MHMarwa Houssein
Marwa Houssein

28 September 2022 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
CTChrysoula Tsirigoti
Chrysoula Tsirigoti
MAMohamad Moustafa Ali
Mohamad Moustafa Ali
VMVarun Maturi
Varun Maturi
CHCarl-Henrik Heldin
Carl-Henrik Heldin
AMAristidis Moustakas
Aristidis Moustakas
The transcription factor SNAI1 mediates epithelial-mesenchymal transition, fibroblast activation and controls inter-tissue migration. High SNAI1 expression characterizes metastatic triple-negative breast carcinomas, and its knockout by CRISPR/Cas9 uncovered an epithelio-mesenchymal phenotype accompanied by reduced signaling by the cytokine TGFβ. The SNAI1 knockout cells exhibited plasticity in differentiation, drifting towards the luminal phenotype, gained stemness potential and could differentiate into acinar mammospheres in 3D culture. Loss of SNAI1 de-repressed the transcription factor FOXA1, a pioneering factor of mammary luminal progenitors. FOXA1 induced a specific gene program, including the androgen receptor (AR). Inhibiting AR via a specific antagonist regenerated the basal phenotype and blocked acinar differentiation. Thus, loss of SNAI1 in the context of triple-negative breast carcinoma cells promotes an intermediary luminal progenitor phenotype that gains differentiation plasticity based on the dual transcriptional action of FOXA1 and AR. This function of SNAI1 provides means to separate cell invasiveness from progenitor cell de-differentiation as independent cellular programs.

5 March 2021 in Oncogene
Verified
Journal Article
Closed access
PDF file
MAMohamad Moustafa Ali
Mohamad Moustafa Ali
MMMirco Di Marco
Mirco Di Marco
SMSagar Mahale
Sagar Mahale
DJDaniel Jachimowicz
Daniel Jachimowicz
SKSubazini Thankaswamy Kosalai
Subazini Thankaswamy Kosalai
CKChandrasekhar Kanduri
Chandrasekhar Kanduri